GlassScriptPhysician profile
Tracey Roth
NPI 1710970561
$3,369.79
in general payments reported to CMS, 2019-2025
24 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $187 · 2021: $523 · 2022: $184 · 2023: $559 · 2024: $1,039 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $598.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $351.87 | 2023-2025 | |
| Abiomed | $290.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.11 | 2022-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $204.93 | 2024 | Optimizer |
| Shockwave Medical, INC | $195.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $181.26 | 2023-2025 | |
| Boston Scientific Corporation | $178.15 | 2019-2024 | Watchman Flx, Rotablator Rotational Atherectomy System Console Kit, Synergy |
| Alnylam Pharmaceuticals INC. | $164.95 | 2023-2025 | Onpattro |
| Abbott Laboratories | $156.20 | 2019-2021 | |
| Philips North America LLC | $128.24 | 2022-2024 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $117.83 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.49 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $94.44 | 2022-2024 | Xarelto |
| Pfizer INC. | $83.76 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $76.37 | 2024-2025 | Nexletol |
| Scpharmaceuticals INC. | $55.88 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $41.76 | 2023 | Inpefa |
| Baxter Healthcare | $39.38 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Chiesi USA, INC. | $34.75 | 2021-2022 | |
| Imperative Care, INC | $24.15 | 2024 | Symphony Catheter |
| Terumo Medical Corporation | $19.92 | 2021 | |
| Sage Therapeutics, LLC | $18.00 | 2025 | Zurzuvae |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.